In addition, in a cervical cancer study, Wang et al. [110] reported that tRF-Glu49 inhibited the proliferation of cervical cancer cells by targeting fibrinogen-like protein-1 (FGL1), an acute inflammatory factor secreted by the liver that is closely related to tumor proliferation and apoptosis [111]. This evidence concerns the gene FGL1 and cervical carcinoma.